Diabetic Foot Ulcers Treatment Market World's Top Player Include 3M Healthcare, Coloplast A/S, B.Braun Melsungen AG, Acelity L.P. Inc., Smith & Nephew Plc., Medtronic Plc, ConvaTec

The global diabetic foot ulcers treatment market by Ulcer Type (Neuropathic Ulcers, and Neuro-Ischemic Ulcers); by Product Type (Wound Care Dressings (Foam dressings, Hydrocolloid Dressing, Hydrogel Dressing, Alginate Dressing, and Other Dressings), Biologics (Growth factors, and Skin Graft and Skin Substitute), Therapy Devices (Negative pressure wound devices, Hyperbaric Oxygen therapy devices, and Other Therapy Devices), and Other Products); by End User (Hospital, Clinics, Ambulatory Surgical Center, and Homecare Setting) and by Region (North America, Latin America, Europe, the Middle East, Asia Pacific, and Africa) is estimated at US$ 1,209.4 million in 2017 and is projected to exhibit a CAGR of 9.4% over the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights.

Download PDF Copy @ https://www.coherentmarketinsights.com/insight/request-pdf/1357

Increasing prevalence of diabetes is the leading factor for growth of the market. According to World Health Organization in 2015, an estimated 1.6 million deaths were directly caused by diabetes. Another 2.2 million deaths were attributable to high blood glucose in 2012. This has led to continuous developments and innovation in treatment and prevention of diabetic foot ulcers, which includes, wound dressings, therapy and wound healing agents, which include ointments and spray. This rise in prevalence has also increased demand for research and development in the field of diabetic foot ulcers treatment.

Manufacturers of diabetic foot ulcers are focusing on research and development and new product launches to cater to increasing demand for the treatment of diabetic foot ulcers. For instance, in December 2017, the Food and Drug Administration (FDA) approved Sanuwave’s Dermapace system, a shock wave therapy system for the treatment of diabetic foot ulcers.

Manufacturers are focusing on expanding the company’s presence in the diabetic foot ulcers treatment market through mergers and acquisitions strategy, which in turn is expected to favor the growth of diabetic foot ulcers in the near future. For instance, Medela Inc. in May 2017, introduced its new Invia FItPad negative pressure wound therapy dressing portfolio enabling dynamic measurement of pressure setting from pump to the dressing site, making it easier for healthcare professionals and patients.

Furthermore, In May 2017, Acelity launched PREVENA DUO Incision Management System in U.S., which is the first single-use negative pressure wound therapy system designed for simultaneous management of two closed surgical incisions and helps to reduce post-operative complications in surgery.

Key takeaways of the market:

The global diabetic foot ulcers treatment market is expected to exhibit a CAGR of 9.4% over the forecast period (2017–2025), and owing to rising prevalence of diabetes the North America is expected to dominate the market. As according to American Diabetes Organization in 2015, it was estimated that there is a increase of patients from 30.3 million Americans in 2015 than 29.6million in 2014, suffers from diabetes.

Asia Pacific market is expected to exhibit a high growth rate, in terms of value, over the forecast period, as key players in the diabetic foot ulcers treatment manufactures are focusing on expanding their presence in the market in Asia Pacific.

Among type segments, wound dressings is expected to exhibit fastest growth over the forecast period, due to technological advancements in wound care technology.

Some major players operating in the global diabetic foot ulcers treatment market are 3M Healthcare Ltd, Coloplast A/S, B.Braun Melsungen AG, Acelity L.P. Inc., Smith & Nephew Plc., Medtronic Plc, ConvaTec Inc., and Mölnlycke Health Care.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.